1H3.SI stock down 50.00% intraday 16 Feb 2026: valuation and liquidity check

Clearbridge Health Limited (1H3.SI stock) plunged 50.00% intraday to S$0.001 on 16 Feb 2026 on the Singapore Exchange (SES). The drop followed thin trading, with volume 50,200 versus an average of 7,261,517 shares. We focus on valuation, liquidity and near-term catalysts for this healthcare small cap. Investors should weigh the steep intraday move against weak recent fundamentals and a thin trading profile.

Intraday price action for 1H3.SI stock

Clearbridge Health Limited (1H3.SI stock) fell 50.00% to S$0.001 on 16 Feb 2026, from an open of S$0.002. Trading volume was 50,200 shares, about 0.69% of average volume. The one-day return ties to limited liquidity and a low floating market cap of S$4,295,821.00 on SES.

Financials and valuation for 1H3.SI stock

Revenue fell to S$9.90 million in 2024, down 4.84% year-on-year, while losses narrowed to S$3.61 million. Key ratios show pressure: P/B 0.13, P/S 0.58, and negative TTM PE. Book value per share is S$0.00850, while cash per share is S$0.00060. These figures explain why the stock trades at low nominal prices despite an underperforming profit profile. For filings and historic financials see the company website and data provider Clearbridge Health and StockAnalysis financials.

Technicals and trading metrics for 1H3.SI stock

The 50-day average price is S$0.00192 and the 200-day average is S$0.00263, both above the current price. Momentum indicators show oversold readings: RSI 37.56 and CCI -155.56. Average daily volume is 7,261,517 shares, so today’s 50,200 indicates extreme illiquidity and high execution risk.

Meyka AI rates and forecast for 1H3.SI stock

Meyka AI rates 1H3.SI with a score out of 100: 61.47 (Grade B, Suggestion: HOLD). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a one-year target of S$0.00743, implying an upside of 643.31% from S$0.001, and a three-year target of S$0.01857. Forecasts are model-based projections and not guarantees.

Risks and catalysts for 1H3.SI stock

Major risks include ultra-low liquidity, negative operating cash flow, and limited analyst coverage. Interest coverage is weak at -3.82, and return on equity is -19.95%, highlighting profitability strain. A possible catalyst is the earnings announcement scheduled for 27 Feb 2026, which could move price if guidance changes. Sector trends matter: Singapore healthcare peers show stronger metrics, with the Healthcare sector 1Y performance at 27.59%, underscoring relative weakness for Clearbridge.

Trading strategy and analyst view for 1H3.SI stock

We recommend cautious, short-term-focused approaches for 1H3.SI stock given volatility and low liquidity. Active traders should size positions small and use limit orders. Long-term investors should wait for clear earnings improvement or structural changes in cash flow. The company’s strategy includes imaging and clinic services across Asia, which can support recovery if execution improves.

Final Thoughts

Clearbridge Health (1H3.SI stock) showed a sharp intraday drop of 50.00% to S$0.001 on 16 Feb 2026, driven by very thin volume and weak fundamentals. Valuation metrics such as P/B 0.13 and P/S 0.58 reflect low market expectations, while profitability measures remain negative. Meyka AI’s forecast model projects S$0.00743 in one year, implying +643.31% from current levels, but this projection assumes improved earnings and liquidity. Investors must weigh high upside scenarios against real risks: low free cash flow, negative ROE, and an average volume shortfall. We note the upcoming earnings date on 27 Feb 2026 as a potential catalyst. Meyka AI, as an AI-powered market analysis platform, flags this stock for monitoring rather than immediate accumulation. Forecasts are model-based projections and not guarantees.

FAQs

Why did 1H3.SI stock drop 50% intraday?

The 50.00% intraday drop on 16 Feb 2026 followed thin trading and low liquidity, with only 50,200 shares traded versus a 7,261,517 average. Market orders in illiquid stocks can cause large price moves.

What is Meyka AI’s rating for 1H3.SI stock?

Meyka AI rates 1H3.SI with a score out of 100: 61.47, Grade B, Suggestion HOLD. The grade factors in benchmarks, sector performance, financial growth, metrics and consensus.

What price forecast exists for 1H3.SI stock?

Meyka AI’s forecast model projects a one-year price of S$0.00743, implying about +643.31% from the S$0.001 current price. Forecasts are model-based projections and not guarantees.

Is 1H3.SI stock a buy after the fall?

Given negative profitability, weak cash flow, and very low liquidity, we advise caution. Investors should wait for stronger earnings or clearer liquidity improvements before adding material positions.

Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.